Nephros Retained Earnings (Accumulated Deficit) 2010-2024 | NEPH
Nephros retained earnings (accumulated deficit) from 2010 to 2024. Retained earnings (accumulated deficit) can be defined as profits reinvested in the corporation after dividends have been paid out.
| Nephros Annual Retained Earnings (Accumulated Deficit) (Millions of US $) |
|
|---|---|
| 2024 | $-144 |
| 2023 | $-144 |
| 2022 | $-143 |
| 2021 | $-136 |
| 2020 | $-132 |
| 2019 | $-127 |
| 2018 | $-124 |
| 2017 | $-121 |
| 2016 | $-120 |
| 2015 | $-117 |
| 2014 | $-114 |
| 2013 | $-107 |
| 2012 | $-98 |
| 2011 | $-94 |
| 2010 | $-92 |
| 2009 | $-90 |
| Nephros Quarterly Retained Earnings (Accumulated Deficit) (Millions of US $) |
|
|---|---|
| 2024-12-31 | $-144 |
| 2024-09-30 | $-145 |
| 2024-06-30 | $-145 |
| 2024-03-31 | $-145 |
| 2023-12-31 | $-144 |
| 2023-09-30 | $-144 |
| 2023-06-30 | $-144 |
| 2023-03-31 | $-143 |
| 2022-12-31 | $-143 |
| 2022-09-30 | $-142 |
| 2022-06-30 | $-139 |
| 2022-03-31 | $-138 |
| 2021-12-31 | $-136 |
| 2021-09-30 | $-135 |
| 2021-06-30 | $-134 |
| 2021-03-31 | $-132 |
| 2020-12-31 | $-132 |
| 2020-09-30 | $-131 |
| 2020-06-30 | $-130 |
| 2020-03-31 | $-128 |
| 2019-12-31 | $-127 |
| 2019-09-30 | $-127 |
| 2019-06-30 | $-126 |
| 2019-03-31 | $-126 |
| 2018-12-31 | $-124 |
| 2018-09-30 | $-123 |
| 2018-06-30 | $-123 |
| 2018-03-31 | $-122 |
| 2017-12-31 | $-121 |
| 2017-09-30 | $-122 |
| 2017-06-30 | $-122 |
| 2017-03-31 | $-121 |
| 2016-12-31 | $-120 |
| 2016-09-30 | $-120 |
| 2016-06-30 | $-119 |
| 2016-03-31 | $-118 |
| 2015-12-31 | $-117 |
| 2015-09-30 | $-116 |
| 2015-06-30 | $-116 |
| 2015-03-31 | $-114 |
| 2014-12-31 | $-114 |
| 2014-09-30 | $-103 |
| 2014-06-30 | $-103 |
| 2014-03-31 | $-102 |
| 2013-12-31 | $-107 |
| 2013-09-30 | $-100 |
| 2013-06-30 | $-99 |
| 2013-03-31 | $-99 |
| 2012-12-31 | $-98 |
| 2012-09-30 | $-96 |
| 2012-06-30 | $-96 |
| 2012-03-31 | $-95 |
| 2011-12-31 | $-94 |
| 2011-09-30 | $-94 |
| 2011-06-30 | $-93 |
| 2011-03-31 | $-93 |
| 2010-12-31 | $-92 |
| 2010-09-30 | $-91 |
| 2010-06-30 | $-91 |
| 2010-03-31 | $-91 |
| 2009-12-31 | $-90 |
| 2009-09-30 | |
| 2009-06-30 | |
| 2009-03-31 | $-89 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Products Manufacturing | $0.017B | $0.014B |
| Nephros develops advanced End Stage Renal Disease, or ESRD, therapy technology and products that would address both patient treatment needs and the clinical and financial needs of the treatment provider. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Abbott Laboratories (ABT) | United States | $234.047B | 28.90 |
| Boston Scientific (BSX) | United States | $154.056B | 41.59 |
| Stryker (SYK) | United States | $148.022B | 31.82 |
| EssilorLuxottica (ESLOY) | France | $137.298B | 0.00 |
| Medtronic (MDT) | Ireland | $115.624B | 16.89 |
| Lonza Group Ag (LZAGY) | Switzerland | $46.792B | 0.00 |
| Haleon (HLN) | United Kingdom | $45.950B | 29.85 |
| GE HealthCare Technologies (GEHC) | United States | $41.418B | 20.17 |
| Agilent Technologies (A) | United States | $38.594B | 25.57 |
| ResMed (RMD) | United States | $33.728B | 25.98 |
| Terumo (TRUMY) | Japan | $25.984B | 36.95 |
| Koninklijke Philips (PHG) | Netherlands | $24.420B | 17.44 |
| Zimmer Biomet Holdings (ZBH) | United States | $21.098B | 13.25 |
| Insulet (PODD) | United States | $19.908B | 85.13 |
| Baxter (BAX) | United States | $17.948B | 12.94 |
| Smith & Nephew SNATS (SNN) | United Kingdom | $11.490B | 0.00 |
| Sunny Optical Technology (SNPTF) | China | $11.331B | 0.00 |
| BellRing Brands (BRBR) | United States | $9.348B | 35.03 |
| Demant (WILYY) | Denmark | $8.092B | 0.00 |
| Bio-Rad Laboratories (BIO) | United States | $7.847B | 27.17 |
| Lantheus Holdings (LNTH) | United States | $5.489B | 12.75 |
| Prestige Consumer Healthcare (PBH) | United States | $4.215B | 20.11 |
| ICU Medical (ICUI) | United States | $3.924B | 37.35 |
| Envista Holdings (NVST) | United States | $3.683B | 29.30 |
| Perrigo (PRGO) | Ireland | $3.443B | 10.14 |
| Haemonetics (HAE) | United States | $3.312B | 15.58 |
| Shandong Weigao Medical Polymer (SHWGF) | China | $2.989B | 0.00 |
| GN Store Nord (GNNDY) | Denmark | $2.850B | 19.20 |
| QuidelOrtho (QDEL) | United States | $2.822B | 23.71 |
| LeMaitre Vascular (LMAT) | United States | $2.294B | 55.75 |
| Neogen (NEOG) | United States | $2.261B | 26.05 |
| AtriCure (ATRC) | United States | $1.916B | 0.00 |
| Green Thumb Industries (GTBIF) | United States | $1.494B | 26.06 |
| InMode (INMD) | Israel | $1.330B | 11.12 |
| BioLife Solutions (BLFS) | United States | $1.193B | 0.00 |
| AdaptHealth (AHCO) | United States | $1.150B | 8.22 |
| Maravai LifeSciences Holdings (MRVI) | United States | $1.013B | 0.00 |
| Curaleaf Holdings (CURLF) | Canada | $0.920B | 0.00 |
| CeriBell (CBLL) | United States | $0.911B | 0.00 |
| Phibro Animal Health (PAHC) | United States | $0.896B | 13.74 |
| Evolus (EOLS) | United States | $0.893B | 0.00 |
| Capricor Therapeutics (CAPR) | United States | $0.657B | 0.00 |
| Valneva SE (VALN) | France | $0.635B | 0.00 |
| VAREX IMAGING (VREX) | United States | $0.538B | 23.32 |
| Omeros (OMER) | United States | $0.503B | 0.00 |
| Surmodics (SRDX) | United States | $0.501B | 0.00 |
| Owens & Minor (OMI) | United States | $0.493B | 3.85 |
| SNDL (SNDL) | Canada | $0.439B | 0.00 |
| Cresco Labs (CRLBF) | United States | $0.432B | 0.00 |
| ZimVie (ZIMV) | United States | $0.368B | 30.98 |
| SEMPERIT AG HLD (SEIGY) | Austria | $0.349B | 0.00 |
| Verano Holdings (VRNOF) | United States | $0.349B | 0.00 |
| Quanterix (QTRX) | United States | $0.311B | 0.00 |
| Sanara MedTech (SMTI) | United States | $0.309B | 0.00 |
| Aurora Cannabis (ACB) | Canada | $0.308B | 56.10 |
| Cerus (CERS) | United States | $0.305B | 0.00 |
| Viemed Healthcare (VMD) | United States | $0.300B | 28.52 |
| OraSure Technologies (OSUR) | United States | $0.298B | 19.95 |
| Biote (BTMD) | United States | $0.252B | 5.52 |
| Canopy Growth (CGC) | Canada | $0.252B | 0.00 |
| Zynex (ZYXI) | United States | $0.234B | 49.07 |
| Sanuwave Health (SNWV) | United States | $0.231B | 3.24 |
| High Tide (HITI) | Canada | $0.205B | 0.00 |
| Utah Medical Products (UTMD) | United States | $0.204B | 15.21 |
| Brainsway (BWAY) | Israel | $0.184B | 97.80 |
| TriSalus Life Sciences (TLSI) | United States | $0.168B | 0.00 |
| MacroGenics (MGNX) | United States | $0.166B | 0.00 |
| TerrAscend (TSNDF) | Canada | $0.164B | 0.00 |
| Organigram Holdings (OGI) | Canada | $0.154B | 0.00 |
| FitLife Brands (FTLF) | United States | $0.137B | 17.17 |
| Jin Medical (ZJYL) | China | $0.114B | 0.00 |
| Quipt Home Medical (QIPT) | United States | $0.114B | 0.00 |
| Fonar (FONR) | United States | $0.092B | 12.92 |
| Oramed Pharmaceuticals (ORMP) | United States | $0.087B | 0.00 |
| Veru (VERU) | United States | $0.083B | 0.00 |
| InterCure (INCR) | Israel | $0.076B | 0.00 |
| Jushi Holdings (JUSHF) | United States | $0.069B | 0.00 |
| Exagen (XGN) | United States | $0.063B | 0.00 |
| Cytosorbents (CTSO) | United States | $0.060B | 0.00 |
| Rockwell Medical (RMTI) | United States | $0.057B | 29.17 |
| Apyx Medical (APYX) | United States | $0.054B | 0.00 |
| Hongchang (HCIL) | China | $0.051B | 0.00 |
| United-Guardian (UG) | United States | $0.046B | 13.24 |
| ImmuCell (ICCC) | United States | $0.045B | 0.00 |
| Modular Medical (MODD) | United States | $0.042B | 0.00 |
| INLIF (INLF) | $0.032B | 0.00 | |
| Safety Shot (SHOT) | United States | $0.028B | 0.00 |
| Trinity Biotech (TRIB) | Ireland | $0.015B | 0.00 |
| Cellectar Biosciences (CLRB) | United States | $0.014B | 0.00 |
| Flora Growth (FLGC) | United States | $0.013B | 0.00 |
| Innovative Eyewear (LUCY) | United States | $0.010B | 0.00 |
| NeuroMetrix (NURO) | United States | $0.009B | 0.00 |
| Meihua Medical Technologies (MHUA) | China | $0.009B | 0.00 |
| Allurion Technologies (ALUR) | United States | $0.009B | 0.00 |
| Agape ATP (ATPC) | $0.006B | 0.00 | |
| IM Cannabis (IMCC) | Canada | $0.005B | 0.00 |
| GlucoTrack (GCTK) | United States | $0.004B | 0.00 |
| Senestech (SNES) | United States | $0.003B | 0.00 |
| Akanda (AKAN) | United Kingdom | $0.002B | 0.00 |
| Sharps Technology (STSS) | United States | $0.002B | 0.00 |
| InVivo Therapeutics Holdings (NVIVQ) | United States | $0.000B | 0.00 |